Drug Shortage Report for KAYEXALATE
| Report ID | 72245 |
| Drug Identification Number | 02026961 |
| Brand name | KAYEXALATE |
| Common or Proper name | Kayexelate |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM POLYSTYRENE SULFONATE |
| Strength(s) | 100% |
| Dosage form(s) | POWDER |
| Route of administration | ORAL RECTAL |
| Packaging size | 454g |
| ATC code | V03AE |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2019-01-14 |
| Actual start date | |
| Estimated end date | 2019-02-08 |
| Actual end date | 2019-02-05 |
| Shortage status | Resolved |
| Updated date | 2019-02-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2019-02-06 | English | Compare |
| v6 | 2019-02-05 | French | Compare |
| v5 | 2019-02-05 | English | Compare |
| v4 | 2019-01-30 | French | Compare |
| v3 | 2019-01-30 | English | Compare |
| v2 | 2019-01-15 | French | Compare |
| v1 | 2019-01-15 | English | Compare |
Showing 1 to 7 of 7